Metabolomics: A biomarker to improve the assessment of central nervous system positive acute lymphoblastic leukaemia? Moppett J. Br J Haematol 2022;198:939-940.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Moppett J. Metabolomics: A biomarker to improve the assessment of central nervous system positive acute lymphoblastic leukaemia? Br J Haematol 2022;198:939-940.
PMID: 35852474